We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News

Executive Summary

Pharmaceutical and biotech firms will have broader patent protection after an appeals court drew a narrow definition of what constitutes a natural phenomenon in the biotech arena. Specifically, the court ruled that a test to measure a drug's metabolites in order to determine the proper drug dosage is patentable subject matter